v35 Search Results


fitc annexin v apoptosis detection kit  (Cytek Biosciences)
94
Cytek Biosciences fitc annexin v apoptosis detection kit
A Cell viability test by the MTT assay of two clones for each homozygous deletion of the indicated GATOR1 components. Cells were treated with 50 μM cisplatin for 24 h. B Identification of IC 50 in clone #2 for each GATOR1 deletion in cells treated with different cisplatin concentrations by the MTT test, as in ( A ). C Cell proliferation assay in the indicated BEAS-2B cell lines. Note that for this assay, cells were treated with 10 μM cisplatin, since 50 μM cisplatin was too high in this setting. See the “Materials and methods” section for details. D Analysis of <t>apoptosis</t> by Annexin V/7-AAD assay and caspase 3 cleavage ( E ). F MTT analysis of cisplatin sensitivity in GATOR1 deletion cells transfected with the indicated plasmids for 36 h. Representative Western blot images from three independent experiments are shown in ( B , E , and F ). G Western blot analysis of the expression of different GATOR1 components in the indicated deletion cell lines, with or without cisplatin treatment (50 μM, 24 h). H Western blot analysis of expression of GATOR1 components when one of the members is overexpressed.
Fitc Annexin V Apoptosis Detection Kit, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc annexin v apoptosis detection kit/product/Cytek Biosciences
Average 94 stars, based on 1 article reviews
fitc annexin v apoptosis detection kit - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
bbmap v35.85  (SourceForge net)
90
SourceForge net bbmap v35.85
A Cell viability test by the MTT assay of two clones for each homozygous deletion of the indicated GATOR1 components. Cells were treated with 50 μM cisplatin for 24 h. B Identification of IC 50 in clone #2 for each GATOR1 deletion in cells treated with different cisplatin concentrations by the MTT test, as in ( A ). C Cell proliferation assay in the indicated BEAS-2B cell lines. Note that for this assay, cells were treated with 10 μM cisplatin, since 50 μM cisplatin was too high in this setting. See the “Materials and methods” section for details. D Analysis of <t>apoptosis</t> by Annexin V/7-AAD assay and caspase 3 cleavage ( E ). F MTT analysis of cisplatin sensitivity in GATOR1 deletion cells transfected with the indicated plasmids for 36 h. Representative Western blot images from three independent experiments are shown in ( B , E , and F ). G Western blot analysis of the expression of different GATOR1 components in the indicated deletion cell lines, with or without cisplatin treatment (50 μM, 24 h). H Western blot analysis of expression of GATOR1 components when one of the members is overexpressed.
Bbmap V35.85, supplied by SourceForge net, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bbmap v35.85/product/SourceForge net
Average 90 stars, based on 1 article reviews
bbmap v35.85 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
dms-v25r (having a mw of about 17,200 daltons)  (Gelest Inc)
90
Gelest Inc dms-v25r (having a mw of about 17,200 daltons)
A Cell viability test by the MTT assay of two clones for each homozygous deletion of the indicated GATOR1 components. Cells were treated with 50 μM cisplatin for 24 h. B Identification of IC 50 in clone #2 for each GATOR1 deletion in cells treated with different cisplatin concentrations by the MTT test, as in ( A ). C Cell proliferation assay in the indicated BEAS-2B cell lines. Note that for this assay, cells were treated with 10 μM cisplatin, since 50 μM cisplatin was too high in this setting. See the “Materials and methods” section for details. D Analysis of <t>apoptosis</t> by Annexin V/7-AAD assay and caspase 3 cleavage ( E ). F MTT analysis of cisplatin sensitivity in GATOR1 deletion cells transfected with the indicated plasmids for 36 h. Representative Western blot images from three independent experiments are shown in ( B , E , and F ). G Western blot analysis of the expression of different GATOR1 components in the indicated deletion cell lines, with or without cisplatin treatment (50 μM, 24 h). H Western blot analysis of expression of GATOR1 components when one of the members is overexpressed.
Dms V25r (Having A Mw Of About 17,200 Daltons), supplied by Gelest Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dms-v25r (having a mw of about 17,200 daltons)/product/Gelest Inc
Average 90 stars, based on 1 article reviews
dms-v25r (having a mw of about 17,200 daltons) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
bbtools v. 35.68  (SourceForge net)
90
SourceForge net bbtools v. 35.68
A Cell viability test by the MTT assay of two clones for each homozygous deletion of the indicated GATOR1 components. Cells were treated with 50 μM cisplatin for 24 h. B Identification of IC 50 in clone #2 for each GATOR1 deletion in cells treated with different cisplatin concentrations by the MTT test, as in ( A ). C Cell proliferation assay in the indicated BEAS-2B cell lines. Note that for this assay, cells were treated with 10 μM cisplatin, since 50 μM cisplatin was too high in this setting. See the “Materials and methods” section for details. D Analysis of <t>apoptosis</t> by Annexin V/7-AAD assay and caspase 3 cleavage ( E ). F MTT analysis of cisplatin sensitivity in GATOR1 deletion cells transfected with the indicated plasmids for 36 h. Representative Western blot images from three independent experiments are shown in ( B , E , and F ). G Western blot analysis of the expression of different GATOR1 components in the indicated deletion cell lines, with or without cisplatin treatment (50 μM, 24 h). H Western blot analysis of expression of GATOR1 components when one of the members is overexpressed.
Bbtools V. 35.68, supplied by SourceForge net, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bbtools v. 35.68/product/SourceForge net
Average 90 stars, based on 1 article reviews
bbtools v. 35.68 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
bbmap v35.92  (SourceForge net)
90
SourceForge net bbmap v35.92
A Cell viability test by the MTT assay of two clones for each homozygous deletion of the indicated GATOR1 components. Cells were treated with 50 μM cisplatin for 24 h. B Identification of IC 50 in clone #2 for each GATOR1 deletion in cells treated with different cisplatin concentrations by the MTT test, as in ( A ). C Cell proliferation assay in the indicated BEAS-2B cell lines. Note that for this assay, cells were treated with 10 μM cisplatin, since 50 μM cisplatin was too high in this setting. See the “Materials and methods” section for details. D Analysis of <t>apoptosis</t> by Annexin V/7-AAD assay and caspase 3 cleavage ( E ). F MTT analysis of cisplatin sensitivity in GATOR1 deletion cells transfected with the indicated plasmids for 36 h. Representative Western blot images from three independent experiments are shown in ( B , E , and F ). G Western blot analysis of the expression of different GATOR1 components in the indicated deletion cell lines, with or without cisplatin treatment (50 μM, 24 h). H Western blot analysis of expression of GATOR1 components when one of the members is overexpressed.
Bbmap V35.92, supplied by SourceForge net, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bbmap v35.92/product/SourceForge net
Average 90 stars, based on 1 article reviews
bbmap v35.92 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
vaxzevria v35  (AstraZeneca ltd)
90
AstraZeneca ltd vaxzevria v35
The SARS-CoV2-VAC antigen microarray was used to investigate immunization status after COVID-19 vaccination. Shown are the results of 35 subjects tested who received BioNTech/Pfizer's Cormirnaty vaccine and 8 subjects tested who received AstraZeneca's <t>Vaxzevria</t> vaccine. Sera taken prior vaccination.
Vaxzevria V35, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vaxzevria v35/product/AstraZeneca ltd
Average 90 stars, based on 1 article reviews
vaxzevria v35 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cement type cemii/b-v, 35% fa  (CEM Corporation)
90
CEM Corporation cement type cemii/b-v, 35% fa
The SARS-CoV2-VAC antigen microarray was used to investigate immunization status after COVID-19 vaccination. Shown are the results of 35 subjects tested who received BioNTech/Pfizer's Cormirnaty vaccine and 8 subjects tested who received AstraZeneca's <t>Vaxzevria</t> vaccine. Sera taken prior vaccination.
Cement Type Cemii/B V, 35% Fa, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cement type cemii/b-v, 35% fa/product/CEM Corporation
Average 90 stars, based on 1 article reviews
cement type cemii/b-v, 35% fa - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
bbmap v35.66  (SourceForge net)
90
SourceForge net bbmap v35.66
The SARS-CoV2-VAC antigen microarray was used to investigate immunization status after COVID-19 vaccination. Shown are the results of 35 subjects tested who received BioNTech/Pfizer's Cormirnaty vaccine and 8 subjects tested who received AstraZeneca's <t>Vaxzevria</t> vaccine. Sera taken prior vaccination.
Bbmap V35.66, supplied by SourceForge net, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bbmap v35.66/product/SourceForge net
Average 90 stars, based on 1 article reviews
bbmap v35.66 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
bbmap v35.43  (SourceForge net)
90
SourceForge net bbmap v35.43
The SARS-CoV2-VAC antigen microarray was used to investigate immunization status after COVID-19 vaccination. Shown are the results of 35 subjects tested who received BioNTech/Pfizer's Cormirnaty vaccine and 8 subjects tested who received AstraZeneca's <t>Vaxzevria</t> vaccine. Sera taken prior vaccination.
Bbmap V35.43, supplied by SourceForge net, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bbmap v35.43/product/SourceForge net
Average 90 stars, based on 1 article reviews
bbmap v35.43 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
bbmap v35  (SourceForge net)
90
SourceForge net bbmap v35
The SARS-CoV2-VAC antigen microarray was used to investigate immunization status after COVID-19 vaccination. Shown are the results of 35 subjects tested who received BioNTech/Pfizer's Cormirnaty vaccine and 8 subjects tested who received AstraZeneca's <t>Vaxzevria</t> vaccine. Sera taken prior vaccination.
Bbmap V35, supplied by SourceForge net, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bbmap v35/product/SourceForge net
Average 90 stars, based on 1 article reviews
bbmap v35 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
bbtools v35  (SourceForge net)
90
SourceForge net bbtools v35

Bbtools V35, supplied by SourceForge net, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bbtools v35/product/SourceForge net
Average 90 stars, based on 1 article reviews
bbtools v35 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
bbmap v35.34  (SourceForge net)
90
SourceForge net bbmap v35.34

Bbmap V35.34, supplied by SourceForge net, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bbmap v35.34/product/SourceForge net
Average 90 stars, based on 1 article reviews
bbmap v35.34 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


A Cell viability test by the MTT assay of two clones for each homozygous deletion of the indicated GATOR1 components. Cells were treated with 50 μM cisplatin for 24 h. B Identification of IC 50 in clone #2 for each GATOR1 deletion in cells treated with different cisplatin concentrations by the MTT test, as in ( A ). C Cell proliferation assay in the indicated BEAS-2B cell lines. Note that for this assay, cells were treated with 10 μM cisplatin, since 50 μM cisplatin was too high in this setting. See the “Materials and methods” section for details. D Analysis of apoptosis by Annexin V/7-AAD assay and caspase 3 cleavage ( E ). F MTT analysis of cisplatin sensitivity in GATOR1 deletion cells transfected with the indicated plasmids for 36 h. Representative Western blot images from three independent experiments are shown in ( B , E , and F ). G Western blot analysis of the expression of different GATOR1 components in the indicated deletion cell lines, with or without cisplatin treatment (50 μM, 24 h). H Western blot analysis of expression of GATOR1 components when one of the members is overexpressed.

Journal: Cell Death & Disease

Article Title: GATOR1 complex controls cisplatin sensitivity

doi: 10.1038/s41419-025-08392-4

Figure Lengend Snippet: A Cell viability test by the MTT assay of two clones for each homozygous deletion of the indicated GATOR1 components. Cells were treated with 50 μM cisplatin for 24 h. B Identification of IC 50 in clone #2 for each GATOR1 deletion in cells treated with different cisplatin concentrations by the MTT test, as in ( A ). C Cell proliferation assay in the indicated BEAS-2B cell lines. Note that for this assay, cells were treated with 10 μM cisplatin, since 50 μM cisplatin was too high in this setting. See the “Materials and methods” section for details. D Analysis of apoptosis by Annexin V/7-AAD assay and caspase 3 cleavage ( E ). F MTT analysis of cisplatin sensitivity in GATOR1 deletion cells transfected with the indicated plasmids for 36 h. Representative Western blot images from three independent experiments are shown in ( B , E , and F ). G Western blot analysis of the expression of different GATOR1 components in the indicated deletion cell lines, with or without cisplatin treatment (50 μM, 24 h). H Western blot analysis of expression of GATOR1 components when one of the members is overexpressed.

Article Snippet: The FITC Annexin V apoptosis detection kit with 7-AAD (TNB35-6410-KIT) was from TONBO Bioscience.

Techniques: MTT Assay, Clone Assay, Proliferation Assay, Transfection, Western Blot, Expressing

The SARS-CoV2-VAC antigen microarray was used to investigate immunization status after COVID-19 vaccination. Shown are the results of 35 subjects tested who received BioNTech/Pfizer's Cormirnaty vaccine and 8 subjects tested who received AstraZeneca's Vaxzevria vaccine. Sera taken prior vaccination.

Journal: Scientific Reports

Article Title: Development of a new antigen-based microarray platform for screening and detection of human IgG antibodies against SARS-CoV-2

doi: 10.1038/s41598-022-10823-7

Figure Lengend Snippet: The SARS-CoV2-VAC antigen microarray was used to investigate immunization status after COVID-19 vaccination. Shown are the results of 35 subjects tested who received BioNTech/Pfizer's Cormirnaty vaccine and 8 subjects tested who received AstraZeneca's Vaxzevria vaccine. Sera taken prior vaccination.

Article Snippet: One sample (V35, AstraZeneca's Vaxzevria vaccine) was taken 4 weeks after the first vaccination, three samples (V25-V27, BioNTech/Pfizer's Comirnaty) after the 2nd vaccination.

Techniques: Microarray

Journal: iScience

Article Title: Functional enrichment of integrons: Facilitators of antimicrobial resistance and niche adaptation

doi: 10.1016/j.isci.2023.108301

Figure Lengend Snippet:

Article Snippet: BBTools v35 , Bushnell , https://sourceforge.net/projects/bbmap/.

Techniques: Virus, Recombinant, Ligation, Sequencing, Software